Skip to main content

UK - Department of Health and Social Care (DHSC)

Global Antimicrobial Resistance Innovation Fund (GAMRIF) – InnoVet AMR: Innovative Veterinary Solutions for AMR with IDRC

Disclaimer: The data for this page has been produced from IATI data published by UK - Department of Health and Social Care (DHSC). Please contact them if you have any questions about their data.

Project Data Last Updated: 11/09/2019

IATI Identifier: GB-GOV-10-GAMRIF-WP3-InnoVet-AMR


InnoVet-AMR is a partnership between DHSC and the International Development Research Centre (IDRC) aimed at reducing the emerging risk that antimicrobial resistance (AMR) in animals poses to global health and food security. InnoVet-AMR will fund research to develop new animal vaccines and other innovations to fight AMR in livestock (swine and poultry) and aquaculture production, particularly in low- and middle-income countries (LMICs).


Through InnoVet-AMR, IDRC and DHSC aim to achieve two main objectives: (1) support research that will identify innovative veterinary solutions, including vaccines and alternative solutions, to reduce the use of antimicrobials in livestock and aquaculture operations in LMICs; (2) build effective partnerships to better coordinate discovery, development and sustainable delivery of affordable innovative veterinary solutions to reduce the use of antimicrobials in livestock and aquaculture operations in LMICs.

Target Groups

Projects funded through the Global AMR Innovation Fund (GAMRIF) will primarily benefit people in LMICs, where the burden of drug-resistant infection is greater.

Status - Implementation More information about project status
Project Spend More information about project funding
Participating Organisation(s) More information about implementing organisation(s)

Sectors groups as a percentage of country budgets according to the Development Assistance Committee's classifications.


A comparison of forecast spend and the total amount of money spent on the project to date.